Dan H Barouch Selected Research

Severe Acute Respiratory Syndrome

1/2022

Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dan H Barouch Research Topics

Disease

99	Infections 05/2024 - 01/2002
58	COVID-19 12/2024 - 01/2020
11	Neoplasms (Cancer) 01/2024 - 09/2013
10	Vaccinia 03/2024 - 03/2009
10	Viremia 01/2022 - 03/2003
9	Inflammation (Inflammations) 01/2022 - 04/2014
8	Acquired Immunodeficiency Syndrome (AIDS) 12/2018 - 01/2002
7	Virus Diseases (Viral Diseases) 12/2023 - 06/2002
7	HIV Infections (HIV Infection) 01/2022 - 01/2016
7	Zika Virus Infection 01/2021 - 10/2016
6	Communicable Diseases (Infectious Diseases) 01/2023 - 07/2005
6	Weight Loss (Weight Reduction) 01/2022 - 01/2020
4	Thrombosis (Thrombus) 10/2023 - 11/2020
4	Pain (Aches) 10/2021 - 01/2020
4	Melanoma (Melanoma, Malignant) 01/2021 - 01/2017
3	Smallpox (Variola) 03/2024 - 07/2008
3	Breakthrough Infections 01/2024 - 09/2012
3	Persistent Infection 01/2022 - 08/2015
3	Headache (Headaches) 10/2021 - 01/2020
3	Disease Progression 01/2021 - 01/2002
3	Fatigue 01/2021 - 01/2020
2	Tuberculosis (Tuberculoses) 06/2023 - 01/2014
2	Asymptomatic Infections 09/2021 - 01/2021
2	Pneumonia (Pneumonitis) 03/2021 - 11/2020
2	Myalgia 01/2021 - 01/2020
2	Dengue (Dengue Fever) 01/2021 - 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2024
1	Thrombocytopenia (Thrombopenia) 10/2023
1	Pre-Eclampsia (Preeclampsia) 01/2023
1	Severe Acute Respiratory Syndrome 01/2022
1	Reinfection 01/2022
1	Common Cold 10/2021

Drug/Important Bio-Agent (IBA)

113	VaccinesIBA 12/2024 - 01/2002
25	AntibodiesIBA 10/2023 - 10/2013
21	Neutralizing AntibodiesIBA 05/2024 - 03/2003
17	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2016
16	Broadly Neutralizing AntibodiesIBA 03/2024 - 03/2016
16	AntigensIBA 01/2024 - 07/2005
13	Ad26COVS1IBA 05/2024 - 01/2021
10	Immunoglobulin G (IgG)IBA 01/2022 - 02/2015
9	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 03/2003
9	Monoclonal AntibodiesIBA 10/2022 - 10/2003
7	mRNA VaccinesIBA 01/2024 - 01/2021
7	Antiviral Agents (Antivirals)IBA 01/2022 - 08/2015
6	Messenger RNA (mRNA)IBA 01/2024 - 11/2020
6	EpitopesIBA 10/2023 - 01/2002
5	COVID-19 VaccinesIBA 12/2023 - 11/2020
5	CytokinesIBA 01/2023 - 01/2002
5	casirivimab and imdevimab drug combinationIBA 10/2022 - 01/2021
3	Glycoproteins (Glycoprotein)IBA 10/2022 - 09/2019
3	vesatolimodIBA 05/2022 - 11/2018
3	Complement System Proteins (Complement)IBA 01/2022 - 02/2015
3	SARS-CoV-2 spike proteinIBA 10/2021 - 10/2020
3	Peptides (Polypeptides)IBA 01/2021 - 01/2017
2	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 03/2024 - 10/2023
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 11/2023 - 02/2022
2	GP 140IBA 05/2022 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	Interferon Type IIBA 01/2022 - 10/2017
2	Angiopoietin-2IBA 10/2021 - 05/2021
2	AKB-9778IBA 10/2021 - 05/2021
2	Interleukin-6 (Interleukin 6)IBA 10/2021 - 11/2020
2	Subunit VaccinesIBA 03/2021 - 07/2008
2	Viral AntigensIBA 01/2021 - 01/2021
2	Serine Proteases (Serine Protease)IBA 12/2020 - 02/2008
2	Polysaccharides (Glycans)IBA 11/2018 - 02/2015
2	Adenovirus VaccinesIBA 01/2018 - 08/2011
2	Viral RNAIBA 01/2016 - 01/2002
2	RNA (Ribonucleic Acid)IBA 06/2010 - 05/2010
2	DNA VaccinesIBA 05/2010 - 07/2005
2	AIDS VaccinesIBA 01/2002 - 01/2002
1	smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA 03/2024
1	ACAM2000IBA 03/2024
1	Programmed Cell Death 1 ReceptorIBA 01/2024
1	B7-H1 AntigenIBA 01/2024
1	N-(2-cyanoethylene)urea (BA 1)IBA 05/2023
1	Interleukin-10 (Interleukin 10)IBA 01/2023
1	aluminum sulfate (alum)IBA 05/2022
1	ADAMTS13 ProteinIBA 05/2022
1	Activins (Activin)IBA 05/2022
1	Indicators and Reagents (Reagents)IBA 05/2022
1	ADM03820IBA 03/2022
1	Immune Sera (Antisera)IBA 01/2022
1	Nucleocapsid ProteinsIBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	GS-CA1IBA 01/2022
1	InterferonsIBA 01/2022
1	bictegravirIBA 11/2021
1	emtricitabine tenofovir alafenamideIBA 11/2021
1	AngiopoietinsIBA 10/2021
1	Immune Checkpoint InhibitorsIBA 10/2021
1	Explosive Agents (Explosives)IBA 10/2021
1	Pattern Recognition ReceptorsIBA 05/2021
1	EmulsionsIBA 05/2021

Therapy/Procedure

16	Therapeutics 03/2022 - 05/2010
3	Art Therapy 01/2019 - 08/2014
2	Aftercare (After-Treatment) 01/2021 - 01/2020
1	Immunotherapy 01/2024
1	Surgical Sponges (Surgical Sponge) 01/2023
1	Intravenous Injections 10/2021